Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Interstitial and orphan lung disease

  • Impact of wait times for treatment on clinical outcomes in patients with obstructive sleep apnoea: protocol for a randomised controlled trial
    Christina S. Thornton, Marcus Povitz, Willis H. Tsai, Andrea H. Loewen, Ada Ip-Buting, Tetyana Kendzerska, W. Ward Flemons, Kristin L. Fraser, Patrick J. Hanly, Sachin R. Pendharkar
    ERJ Open Research Apr 2022, 8 (2) 00068-2022; DOI: 10.1183/23120541.00068-2022
  • Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges
    Namrata Kewalramani, Carlos Machahua, Venerino Poletti, Jacques Cadranel, Athol U. Wells, Manuela Funke-Chambour
    ERJ Open Research Apr 2022, 8 (2) 00115-2022; DOI: 10.1183/23120541.00115-2022
  • Assessing population interest in interstitial lung diseases in the USA using Google Trends
    Niranjan Jeganathan, Essam K. Nagori, Matheni Sathananthan
    ERJ Open Research Apr 2022, 8 (2) 00092-2022; DOI: 10.1183/23120541.00092-2022
  • ERS International Congress 2021: highlights from the Interstitial Lung Diseases Assembly
    Sabina A. Guler, Sara Cuevas-Ocaña, Mouhamad Nasser, Wim A. Wuyts, Marlies S. Wijsenbeek, Antoine Froidure, Elena Bargagli, Elisabetta A. Renzoni, Marcel Veltkamp, Paolo Spagnolo, Hilario Nunes, Cormac McCarthy, Maria Molina-Molina, Francesco Bonella, Venerino Poletti, Michael Kreuter, Katerina M. Antoniou, Catharina C. Moor
    ERJ Open Research Apr 2022, 8 (2) 00640-2021; DOI: 10.1183/23120541.00640-2021
  • Underdiagnosis of cardiac sarcoidosis by ECG and echocardiography in cases of extracardiac sarcoidosis
    Hiroshi Ohira, Takahiro Sato, Osamu Manabe, Noriko Oyama-Manabe, Akiko Hayashishita, Toshitaka Nakaya, Junichi Nakamura, Naoko Suzuki, Ayako Sugimoto, Sho Furuya, Satonori Tsuneta, Taku Watanabe, Ichizo Tsujino, Satoshi Konno
    ERJ Open Research Apr 2022, 8 (2) 00516-2021; DOI: 10.1183/23120541.00516-2021
  • Lung involvement during the prediagnostic phase of idiopathic pleuroparenchymal fibroelastosis
    Takuto Miyamura, Yoshiaki Kinoshita, Hisako Kushima, Hiroshi Mukae, Hiroshi Ishii
    ERJ Open Research Apr 2022, 8 (2) 00548-2021; DOI: 10.1183/23120541.00548-2021
  • Reduced immunogenicity of the mRNA vaccine BNT162b2 in patients with idiopathic pulmonary fibrosis
    Theodoros Karampitsakos, Ourania Papaioannou, Ilias Dimeas, Panagiota Tsiri, Vasilina Sotiropoulou, Ioannis Tomos, Ilias C. Papanikolaou, Matthaios Katsaras, Paraskevi Kirgou, Zoe Daniil, Konstantinos I. Gourgoulianis, Fotios Sampsonas, Effrosyni Manali, Spyridon Papiris, Demosthenes Bouros, Argyris Tzouvelekis
    ERJ Open Research Apr 2022, 8 (2) 00082-2022; DOI: 10.1183/23120541.00082-2022
  • Developing a conceptual model of symptoms and impacts in progressive fibrosing interstitial lung disease to evaluate patient-reported outcome measures
    Marlies Wijsenbeek, Maria Molina-Molina, Olivier Chassany, John Fox, Liam Galvin, Klaus Geissler, Katherine M. Hammitt, Michael Kreuter, Teng Moua, Emily C. O'Brien, Ashley F. Slagle, Anna Krasnow, Matthew Reaney, Michael Baldwin, Natalia Male, Klaus B. Rohr, Jeff Swigris, Katerina Antoniou
    ERJ Open Research Apr 2022, 8 (2) 00681-2021; DOI: 10.1183/23120541.00681-2021
  • Serum autotaxin levels in chronic disease and acute exacerbation of fibrosing interstitial lung disease
    Takuma Isshiki, Hiroshige Shimizu, Susumu Sakamoto, Akira Yamasaki, Shion Miyoshi, Yasuhiko Nakamura, Sakae Homma, Kazuma Kishi
    ERJ Open Research Apr 2022, 8 (2) 00683-2021; DOI: 10.1183/23120541.00683-2021
  • Vascular remodelling in idiopathic pulmonary fibrosis patients and its detrimental effect on lung physiology: potential role of endothelial-to-mesenchymal transition
    Archana Vijay Gaikwad, Wenying Lu, Surajit Dey, Prem Bhattarai, Collin Chia, Josie Larby, Greg Haug, Stephen Myers, Jade Jaffar, Glen Westall, Gurpreet Kaur Singhera, Tillie-Louise Hackett, James Markos, Mathew Suji Eapen, Sukhwinder Singh Sohal
    ERJ Open Research Jan 2022, 8 (1) 00571-2021; DOI: 10.1183/23120541.00571-2021

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 16
  • Acute lung injury and critical care (42)
  • Asthma and allergy (196)
  • CF and non-CF bronchiectasis (121)
  • COPD and smoking (313)
  • Epidemiology, occupational and environmental lung disease (56)
  • Genetics (27)
  • Interstitial and orphan lung disease (155)
  • Lung biology and experimental studies (76)
  • Lung cancer (69)
  • Lung imaging (53)
  • Lung structure and function (99)
  • Mechanisms of lung disease (4)
  • Paediatric pulmonology (100)
  • Pulmonary pharmacology and therapeutics (114)
  • Pulmonary vascular disease (77)
  • Respiratory clinical practice (86)
  • Respiratory infections and tuberculosis (295)
  • Sleep medicine (48)
  • Most Read
  • Twitter
Loading
  • Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?
  • Impact of N-acetyl-l-cysteine on SARS-CoV-2 pneumonia and its sequelae: results from a large cohort study
  • IQOS exposure impairs human airway cell homeostasis: direct comparison with traditional cigarette and e-cigarette
  • Outcomes of COVID-19 patients treated with continuous positive airway pressure outside the intensive care unit
  • The safety of cardioselective β1-blockers in asthma: literature review and search of global pharmacovigilance safety reports
More...

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2022 by the European Respiratory Society